Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN109467552A reveals high-purity Aprepitant manufacturing with reduced impurities and scalable conditions for cost reduction in pharma manufacturing.
Patent CN115572263B reveals hydrazine salt catalysis for pyrazoline. High yield, low waste, scalable process for pharmaceutical and aerospace intermediates.
Novel bactericidal thiazole synthesis via CN110172067B. Optimized route offers cost reduction in antibacterial drug manufacturing and scalable supply chain solutions.
Novel bactericidal thiazole drug molecule synthesis via efficient cyclization. Reduces lead time for high-purity intermediates and ensures supply continuity.
Patent CN113135971A details a high-yield synthesis of carbon-losing cholestanal from duck cholic acid, offering a cost-effective route for API intermediates.
Patent CN100349858C reveals solvent innovation for high-purity iohexol production reducing impurities and enhancing supply chain reliability for contrast agents.
Novel Pd-Cu catalyzed method for phenanthrene intermediates. High yield, mild conditions, scalable for pharmaceutical manufacturing supply chains.
Patent CN115286559B reveals a three-step route for Paxlovid key intermediate offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN112174970B reveals a scalable method for Pemetrexed Disodium using alkali-modified molecular sieves, ensuring high yield and reduced environmental impact.
Patent CN101245049A offers improved Palbendazole synthesis with reduced waste and cost for veterinary supply chains.
Novel asymmetric acetal method for (1R,5S)-3-ethylbicyclo[3.2.0]hept-3-en-6-one synthesis. High ee%, low cost, scalable process for API manufacturing.
Patent CN106995413A reveals high-ee iridium-catalyzed hydrogenation for chiral piperazines, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN116041272B reveals a metal-free synthesis for benzoxazole derivatives using naphthylamine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN105712914B details a palladium-catalyzed asymmetric thioetherification method offering high regioselectivity and mild conditions for cost reduction in pharma manufacturing.
Patent CN1281587C details a chiral phase transfer catalysis method for single isomer nitrendipine. Achieve high purity and reduced impurities for cardiovascular API manufacturing.
Patent CN100569790C reveals a high-yield 3-step route for Capecitabine intermediates using triphosgene, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN113651707A reveals a high-yield, 3-step synthesis for ortho-amino trifluoroacetophenone. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN110627673B details a high-purity route for Formoterol intermediates using borane reduction, offering significant cost and supply chain advantages for API manufacturers.
Patent CN108558673B reveals a cost-effective Raney Nickel process for high-purity 2-(1-cyclohexenyl)ethylamine, optimizing dextromethorphan intermediate supply chains.
Patent CN105017035B details a high-purity DKR method for chiral intermediates. Achieves >99% ee with scalable catalysts for reliable pharmaceutical supply chains.